コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 specificity, positive predictive value, and negative predictive value.
2 city, 94% positive predictive value, and 94% negative predictive value.
3 tive in over 90% of cases and carries a high negative predictive value.
4 a 93% positive predictive value, and an 88% negative predictive value.
5 city, 17% positive predictive value, and 95% negative predictive value.
6 city, 66% positive predictive value, and 91% negative predictive value.
7 did not significantly affect sensitivity or negative predictive values.
8 effective and cost-saving method, with high negative predictive values.
9 nt recipients with greater than 95% positive/negative predictive values.
10 quadrant demonstrated the best positive and negative predictive values.
12 er sensitivity (100% versus 70%, P<0.05) and negative predictive value (100% versus 89%, P<0.05) than
13 ), specificity (91%), and positive (93%) and negative predictive value (100%) for ISH positivity.
14 k stigmata, had a higher sensitivity (100%), negative predictive value (100%), and accuracy (66%) for
18 ositive predictive value (83-86%) but a poor negative predictive value (50-55%) to detect the presenc
19 specificity was 76.3%, and the positive and negative predictive values 62.2% and 95.7%, respectively
20 7.5 min: sensitivity, 73%; specificity, 67%; negative predictive value, 67%; positive predictive valu
21 of diagnostic sensitivity, specificity, and negative predictive values (70% to 100%) but low positiv
22 7% and 77.5%, respectively) and positive and negative predictive values (74.7% and 78.5%, respectivel
23 > 2.46: sensitivity, 82%; specificity, 89%; negative predictive value, 80%; positive predictive valu
25 to achieve an objective response by RECIST (negative predictive value, 91% [95% CI, 74% to 100%] for
27 ision ruling out sc-TCMR (specificity = 70%, negative predictive value = 92.5%), but could not predic
28 64 [95% CI, 0.61-0.67], respectively; 1-year negative predictive values, 92% [95% CI, 91%-93%] and 91
29 plasma CXCL8 in healthy individuals found a negative predictive value 93.5%, given the population pr
30 e <37 mL/m(2) and strain >23.4% yielded high negative predictive value (93% and 98%, respectively) fo
32 d 100% sensitivity (95% CI, 94-100) and 100% negative predictive value (95% CI, 79-100); regional cer
33 5), 72% specificity (95% CI, 65-79), and 98% negative predictive value (95% CI, 93-100) for cerebral
34 e value (76.7% and 69.2%, respectively), and negative predictive value (95.0% and 99.6%, respectively
35 elihood ratio, positive predictive value and negative predictive values (95% confidence interval): ur
38 ictive value, 61% and 88%, respectively; and negative predictive value, 97% and 97%, respectively.
39 ely, missing 18 index and two 30-day events (negative predictive value, 97.9%; 95% confidence interva
40 airment as low risk for the primary outcome (negative predictive value, 98.4%; 95% confidence interva
41 cificity 93%; positive predictive value 90%; negative predictive value 99%) and lasted 1 single cycle
43 igh sensitivity (97%), specificity (79%) and negative predictive value (99%) to render it useful for
44 tive predictive value (85.8-91.3), and 99.9% negative predictive value (99.9-100.0) in the validation
45 ours, missing 2 index and two 30-day events (negative predictive value, 99.5%; 95% confidence interva
46 pairment (P<0.001) with similar performance (negative predictive value, 99.7%; 95% CI, 99.4%-99.9%; s
47 edictive value) and sNGAL (>/=179 ng/mL; 93% negative predictive value and 20% positive predictive va
48 hours for both urine NGAL (>/=20 ng/mL; 97% negative predictive value and 27% positive predictive va
51 prior expertise in NBI were able to meet the negative predictive value and surveillance interval thre
53 vs. 57%positive predictive value, 95% vs. 94%negative predictive value, and 0.87 vs. 0.82 area under
56 ity, specificity, positive predictive value, negative predictive value, and accuracy of the Hopkins s
57 ity, specificity, positive predictive value, negative predictive value, and diagnostic accuracy of 71
58 cificity, 44% positive predictive value, 80% negative predictive value, and likelihood ratio 1.54 to
59 ity, specificity, positive predictive value, negative predictive value, and likelihood ratio of every
61 l TM) had a better sensitivity, specificity, negative predictive value, and positive predictive value
63 old value was used to determine positive and negative predictive values, and a full logistic regressi
64 ss upgrade and downgrade rates, positive and negative predictive values, and positive and negative li
65 We analyze their development, positive- and negative-predictive values, and ability to predict respo
66 exercise E/e' data improves sensitivity and negative predictive value but compromises specificity, s
67 o>14) improved sensitivity (to 90%) and thus negative predictive value, but decreased specificity (71
68 specificity, positive predictive value, and negative predictive value for (18)F-FDG PET/CT were 82%,
69 characterized with high confidence, a >/=90% negative predictive value for adenomas in the rectosigmo
70 n had 100% positive predictive value and 87% negative predictive value for airway mucosal CCL26-high
74 specificity, positive predictive value, and negative predictive value for an FFR of </=0.8 were 91.4
75 runs yielded a success rate of 92%, and the negative predictive value for both the influenza A and B
77 gative likelihood ratio and the positive and negative predictive value for detection of prostate canc
80 specificity, positive predictive value, and negative predictive value for NLP algorithm in predictin
81 sensitivity, positive predictive value, and negative predictive value for OC/FTC detection within 1
82 specificity, positive predictive value, and negative predictive value for PLC injuries were 55% (11
83 tivity to first-line platinum therapy (94.3% negative predictive value for progression < 6 months).
84 specificity, positive predictive value, and negative predictive value for separating MPNSTs from BNF
85 hen both parameters exceeded thresholds, the negative predictive value for survival above 1 y was 79%
86 specificity, positive predictive value, and negative predictive value for the first step were estima
87 have 95% positive predictive value (PPV) or negative predictive value for the persistence or resolut
88 specificity, positive predictive value, and negative predictive value for the Qiagen artus C. diffic
92 Sensitivity, specificity, and positive and negative predictive values for malignant tumors of the c
93 e sensitivity, specificity, and positive and negative predictive values for the index TKA and revisio
96 e sensitivity, specificity, and positive and negative predictive values for WGS in predicting AMR wer
98 n, an sFlt-1:PlGF ratio of 38 or lower had a negative predictive value (i.e., no preeclampsia in the
100 an adjunct to US to improve sensitivity and negative predictive value in breast cancer diagnosis.
104 0.98, positive predictive value (PPV) 0.87, negative predictive value (NPV) 0.90, and accuracy (Acc)
105 pecificity, positive predictive value (PPV), negative predictive value (NPV) and diagnostic accuracy
106 The positive predictive value (PPV) and negative predictive value (NPV) for each code of interes
107 nt (ED) have been shown to have an excellent negative predictive value (NPV) for the identification o
108 87%-95%, sensitivity of 32%-55% and 50%-67%, negative predictive value (NPV) of 88%-91% and 86%-89%,
109 ive value (PPV) of 93.3% (86.8 to 97.3), and negative predictive value (NPV) of 97.2% (96.0 to 98.2).
111 tive [AFB(-)] sputum), specificity of 99.2%, negative predictive value (NPV) of 97.6%, and positive p
112 ificity of 20.8% (95% CI 19.2%-22.4%), and a negative predictive value (NPV) of 99.8% (95% CI 98.9%-1
114 ficity, positive predictive value (PPV), and negative predictive value (NPV) of MALDI-TOF MS alone an
115 ficity, positive predictive value (PPV), and negative predictive value (NPV) of MRI-based T-staging w
116 ficity, positive predictive value (PPV), and negative predictive value (NPV) of RDTs were 51.7%, 94.1
117 ated the positive predictive value (PPV) and negative predictive value (NPV) of ST for anaphylaxis re
118 ecificity was 0.94 (95% CI: 0.77, 0.99), the negative predictive value (NPV) was 0.92 (95% CI: 0.75,
123 pecificity, positive predictive value (PPV), negative predictive value (NPV), and Cohen's kappa coeff
124 pecificity, positive predictive value (PPV), negative predictive value (NPV), and diagnostic time.
125 pecificity, positive predictive value (PPV), negative predictive value (NPV), and positive likelihood
129 ities, positive predictive values (PPV), and negative predictive values (NPV) were 92.7%, 100%, 100%,
131 ificity, positive predictive value [PPV] and negative predictive value [NPV] of both MR cisternograph
133 atients required neurosurgical intervention (negative predictive value [NPV], 100.0% [95% CI: 99.9%-1
134 predictive value [PPV], 24 [95% CI, 16-32]; negative predictive value [NPV], 92 [95% CI, 87-96]) and
135 ficity, positive predictive value [PPV], and negative predictive value [NPV]; treatment efficacy (COP
136 ulated positive predictive values (PPVs) and negative predictive values (NPVs) by comparing agreement
138 ty, specificity, positive predictive values, negative predictive values (NPVs), and accuracy were cal
139 with an AUC of 0.88 (95% CI 0.79-0.94) and a negative predictive value of 0.92 (95% 0.88-0.95) at the
140 a specificity of 0.83 (95% CI, 0.36-1.0), a negative predictive value of 1.0 (95% CI, 0.48-1.0), and
142 specificity, positive predictive value, and negative predictive value of 100%, 88%, 86%, and 100%, r
143 bviate the need for antifungal agents with a negative predictive value of 100%, whereas the presence
144 ch, with sensitivity of 100.0% and 63.6% and negative predictive value of 100.0% and 66.6%, respectiv
145 onstrated sensitivity, specificity, PPV, and negative predictive value of 47.6%, 93.9%, 55.6%, and 91
146 ficity, positive predictive value (PPV), and negative predictive value of 54.8%, 97.7%, 79.3%, and 93
147 predictive value of 98% (95% CI, 94%-100%), negative predictive value of 66% (95% CI, 56%-75%), spec
151 tive value of 91.3% (95% CI: 73.3-97.6%) and negative predictive value of 78.6% (95% CI: 64.2-88.2%).
152 ctive value of 89.6% (95% CI, 89.1-90.1) and negative predictive value of 79.7% (95% CI, 79.4-80.1).
154 lution to ESRD before 60 years of age with a negative predictive value of 81.4%, a score >6 forecasts
156 specificity, positive predictive value, and negative predictive value of 84.7%, 78.2%, 75%, and 87%,
157 specificity, positive predictive value, and negative predictive value of 85.3%, 93.9%, 27.4%, and 99
158 90-93), sensitivity of 75% (95% CI, 72-78), negative predictive value of 86% (95% CI, 84-88), positi
160 edictive value of 41% (95% CI, 35%-46%), and negative predictive value of 88% (95% CI, 80%-94%).
162 cificity of 100.0% (95% CI, 90.9%-100.0%), a negative predictive value of 89.1% (95% CI, 77.1%-95.5%)
163 specificity, positive predictive value, and negative predictive value of 89.5%, 100%, 100%, and 97.2
167 80 seconds had sensitivity, specificity, and negative predictive value of 92.3%, 92.4%, and 98.6%, re
168 t culture positivity at 2 months with a high negative predictive value of 93% (95% CI, 89 to 96).
169 ensitivity of 88.9% and 63.9% (P = .013) and negative predictive value of 93.1% and 80.9% (P = .045),
170 ecificity, 71.2%; sensitivity, 71.0%, with a negative predictive value of 93.1% and a positive predic
174 a sensitivity of 97%, specificity of 23%, a negative predictive value of 95%, and a positive predict
175 specificity, positive predictive value, and negative predictive value of 96.0% (95% confidence inter
177 a positive predictive value of 71.62% and a negative predictive value of 96.77% in terms of pixel-by
178 ve predictive value of 84.3% (70 of 83), and negative predictive value of 96.9% (157 of 162) for the
179 sensitivity of 81%, specificity of 69%, and negative predictive value of 97% at 6 hours from sample
180 tive value of 88.2% (95% CI 63.6-98.5) and a negative predictive value of 97.8% (92.2-99.7) and ident
181 had a positive predictive value of 83% and a negative predictive value of 98% for identifying partici
182 .0%, positive predictive value of 48.9%, and negative predictive value of 98.3% for the differentiati
183 sitivity of 83.6%, specificity of 82.6%, and negative predictive value of 98.4%, which are pessimisti
184 e predictive value 10% (95% CI, 9%-12%), and negative predictive value of 99% (95% CI, 98%-100%) in t
186 Computed tomographic scans had an overall negative predictive value of 99.2% for patients with CSI
191 ng/L in 2311 (61%) of 3799 patients, with a negative predictive value of 99.6% (95% CI 99.3-99.8) fo
193 6 ng/L, the rule-out algorithm showed a high negative predictive value of 99.8% (95% CI, 98.6%-100.0%
194 value of 99.2% for patients with CSIs and a negative predictive value of 99.8% for ruling out CSIs t
195 hs at 30 days and 7 (0.1%) at 1 year, with a negative predictive value of 99.9% (95% CI, 99.7%-99.9%)
196 specificity, positive predictive value, and negative predictive value of a NRL-sIgE level >/=0.35 kU
197 ion and validation cohorts, we evaluated the negative predictive value of a range of troponin concent
198 The primary outcome was a comparison of the negative predictive value of both pathways for index typ
199 specificity, positive predictive value, and negative predictive value of cMR was 57%, 57%, 27%, and
204 specificity, positive predictive value, and negative predictive value of SE were 51.35 %, 67.33 %, 3
205 his study was to measure the sensitivity and negative predictive value of sentinel-lymph-node mapping
207 Antischemic therapy markedly affects the negative predictive value of stress echocardiography in
208 d TTPVI) was associated with tumor size: The negative predictive value of the absence of worrisome fe
210 mean sensitivity, specificity, positive and negative predictive value of the corresponding optimal c
216 ith radiographic nodules less than 3 cm, the negative predictive value of the TM panel was 71.8%, hen
218 or epileptiform discharges with positive and negative predictive values of 0.71 (95% CI 0.51, 0.87) a
219 8.8%, specificity of 40.1%, and positive and negative predictive values of 17.0% and 99.6%, respectiv
220 6.7% and 52%, respectively, and positive and negative predictive values of 31.9% and 82.2%, respectiv
221 nd a specificity of 47.1%, with positive and negative predictive values of 36.5% and 86.3%, respectiv
222 4%, a specificity of 40.1%, and positive and negative predictive values of 41.1% and 95.2%, respectiv
223 5%, a specificity of 71.4%, and positive and negative predictive values of 45.1% and 98.8%, respectiv
224 h high-risk cirrhosis generates positive and negative predictive values of 80% and 86%, respectively.
225 ence interval, 0.764-0.917) and positive and negative predictive values of 83% and 81%, respectively.
226 with sensitivity, specificity, positive, and negative predictive values of 84%, 80%, 64%, and 92%, re
227 97%, a specificity of 99%, and positive and negative predictive values of 89% and 100% for detecting
228 ost-CRT and ADC change measurements achieved negative predictive values of 96% (44 of 46) to 100% (39
229 YG Carba v2.0 displayed overall positive and negative predictive values of 99.7% (CI95: 95.4-98.9) an
233 e sensitivity, specificity, and positive and negative predictive values of IVCM compared with those o
235 e sensitivity, specificity, and positive and negative predictive values of methacholine challenges at
236 Sensitivity, specificity, and positive and negative predictive values of the Amsler grid scotoma ar
237 Sensitivity, specificity, and positive and negative predictive values of the Amsler grid test were
239 pecificities and calculated the positive and negative predictive values of the Lipsker and of the Str
240 e sensitivity, specificity, and positive and negative predictive values of the methacholine challenge
241 e sensitivity, specificity, and positive and negative predictive values of the Xpert Carba-R assay co
242 te cutoff (ie, one with high sensitivity and negative predictive value) of the MPD diameter on CT or
243 ity, specificity, positive predictive value, negative predictive value, or overall accuracy were foun
246 ning visual score, sensitivity, specificity, negative predictive value, positive predictive value, an
247 lues, sensitivity, specificity, positive and negative predictive values, positive and negative likeli
248 ng sensitivity, specificity and positive and negative predictive value (PPV and NPV) for the two Arab
252 hese data, we conclude that UA has excellent negative predictive value that is not enhanced by urine
253 as assessed by positive predictive value and negative predictive value, that is, the probability of a
255 atients who have low heart rates with a high negative predictive value to rule out coronary artery di
256 specificity, positive predictive value, and negative predictive value using the histopathological di
257 of immunochemotherapy, iPET has a very good negative predictive value, utilizing both visual (qualit
260 lue was 78.6% (95% CI, 60.5%-89.8%), and the negative predictive value was 75.0% (95% CI, 55.1%-88.0%
262 om the 92 segmental pairs, were 82% and 72%, negative predictive value was 81%, and overall positive
263 redictive value was 95% (21 of 22 patients), negative predictive value was 90% (nine of 10 patients),
265 dictive value was 72% (95% CI, 61%-90%), and negative predictive value was 96.4% (95% CI, 90%-98.7%).
266 value was 10.8% (95% CI, 9.6%-11.9%) and the negative predictive value was 97.8% (95% CI, 96.8%-98.6%
268 lue was 33.3% (95% CI, 25.6%-45.5%), and the negative predictive value was 98.1% (95% CI, 96.9%-100%)
269 CI, 86.7-94.5) and for adenomas >/=10 mm the negative predictive value was 98.6% (95% CI, 97.0-100).
276 specificity, positive predictive value, and negative predictive value were 96.6%-100%, 77.3%-83.3%,
277 ty, accuracy, positive predictive value, and negative predictive value were 97%, 95.1%, 96.6%, 98.5%,
278 The readers' positive predictive value and negative predictive value were broadly consistent with e
279 ficity, positive predictive value (PPV), and negative predictive value were calculated for both imagi
281 , 76 to 85, and >85 years, respectively; the negative predictive values were >98% across all age grou
287 3.7% (95% CI, 83.4%-84.0%), and positive and negative predictive values were 72.7% (95% CI, 72.2%-73.
288 test sensitivity, specificity, positive and negative predictive values were 79.2%, 38.5%, 27.6%, and
289 81% and 79%, respectively, and positive and negative predictive values were 81% and 79%, respectivel
292 9.03% and 99.23%, respectively; positive and negative predictive values were 92.01% and 99.91%, respe
293 y was 96%, specificity was 82%, positive and negative predictive values were 93% and 90%, and the are
294 e sensitivity, specificity, and positive and negative predictive values were 98.1%, 39.1%, and 44.0%
296 while sensitivity, specificity, positive and negative predictive values were calculated as 98.1, 94.4
297 ive fractions were 22% and 2%, respectively; negative predictive values were especially low for 10- t
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。